Yaylali E, Farnham PG, Hicks KA, Honeycutt A, Sansom SL, Tucker EL. Developing a dynamic compartmental model of HIV in the United States. Poster presented at the INFORMS Annual Meeting; November 3, 2015. Philadelphia, PA.
Chen YH, Yaylali E, Hicks KA, Tucker EL, Farnham PG, Sansom SL. Calibrating dynamic compartmental models of human immunodeficiency virus in the United States. Poster presented at the Society for Medical Decision Making (SMDM) 37th Annual North American Meeting; October 18, 2015. St. Louis, MO.
Hicks KA, Bowers LD. A model for developing athlete testing strategies based on the costs and benefits of doping. Presented at the 14th Annual USADA Symposium on Anti-Doping Science; October 4, 2015. Leesburg, VA.
Zarkin GA, Cowell AJ, Hicks KA, Mills MJ, Belenko S, Dunlap LJ, Keyes V. Lifetime benefits and costs of diverting substance-abusing offenders from state prison. Crime Delinq. 2015 Aug;61(6):829-50. doi: 10.1177/0011128712461904
Zarkin GA, Dunlap LJ, Hicks KA, Mamo D. Benefits and costs of methadone treatment: results from a lifetime simulation model. Health Econ. 2005 Nov 1;14(11):1133-50.
Rein DB, Hicks KA, Wirth KE, Hoerger TJ. Economics of hepatitis A immunization. Presented at the U.S. Advisory Committee on Immunization Practices; June 2005. Atlanta, GA.
Rein DB, Hicks KA, Wirth KE, Hoerger TJ. Update: economics of hepatitis A virus immunization. Presented at the ACIP Hepatitis Working Group; June 2005.
Rein DB, Hicks KA, Wirth KE, Hoerger TJ. Results of RTI's cost-effectiveness evaluation of childhood hepatitis A vaccination strategies. Presented at the U.S. Advisory Committee on Immunization Practices (ACIP); June 2005. Atlanta, GA.
Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005 Jan 1;142(5):323-32.